Author

Kun Shi‐van Wielink

Observed names: K. Shi-van Wielink, Kun Shi - van Wielink, Kun Shi-van Wielink

ORCID: 0009-0005-4328-1433

Observed ORCID: 0009-0005-4328-1433

OpenAlex ID: A5093566516

Economic evaluation, resource utilisation, and associated economic burden of myopia management: a systematic literature review

2025 · Thom WL de Milliano, Kun Shi-van Wielink, et al. · Journal of Global Health · 11

Cost-Effectiveness Analysis of Low-Dose Atropine Eye Drops (0.01%) for the Treatment of Myopia in Children: A United Kingdom Perspective

2026 · Kun Shi-van Wielink, Annegret Dahlmann-Noor, et al. · PharmacoEconomics · 1

Consensus on evidence gaps and unmet needs in childhood myopia: findings from a European Delphi study with eye care professionals and payers

2026 · Wolf Lagreze, Paolo Nucci, et al. · BMJ Open Ophthalmology · 1

Epidemiology and burden of mild/moderate versus high myopia in Germany: A claims data analysis

2025 · Tarcyane Barata Garcia, Nils Kossack, et al. · Acta Ophthalmologica · 1

RWD133 Cross Sectional Claims Data Analysis on Myopia Epidemiology and Treatment Options in Germany

2023 · M. Pignot, N. Kossack, et al. · Value in Health · 1

The growing burden of myopia in Europe: evidence from population-based cohorts

2026 · Amber Tiemens, Dirk J. van Hemert, et al. · European Journal of Epidemiology

SA104 When Trials Don’t Meet: A Retrospective Statistical Analysis Using Matching-Adjusted Indirect Comparison (MAIC) and Individual Patient Data (IPD) to Compare Catiolanze® With Other Preservative-Free (PF) Latanoprost in Open-Angle Glaucoma (OAG)

2025 · Jieyi Li, Zifan Pei, et al. · Value in Health

MT13 Defining Decision-Making Criteria for Glaucoma Surgery in Non-Refractory, Moderate to Severe Open-Angle Glaucoma: A Stakeholder Analysis Across Multiple Countries with Distinct Payer Archetypes to Support a Multi-Criteria Decision Analysis Framework

2025 · Amber Tiemens, Anniek Bonestroo, et al. · Value in Health

Health-Related Quality of Life Among Patients Suffering from Myopia or its Long-Term Consequences: A Cross-sectional Survey Protocol

2025 · Sarah Dewilde, Julie Boelen, et al. · medRxiv

EPH188 Economic Modelling of Myopia Management: A Systematic Literature Review

2025 · Thom de Milliano, Kun Shi-van Wielink, et al. · Value in Health

EPH34 Systematic Literature Review on the Economic Burden of Myopia

2025 · Thom de Milliano, Kun Shi-van Wielink, et al. · Value in Health

RWD177 Real-World Evidence (RWE) Study on Burden, Healthcare Resource Utilization, & Cost of Illness Among Patients Diagnosed With Myopia in Germany: Retrospective, Longitudinal, Observational Cohort Claims Data Study

2024 · M. Pignot, M. Dagher, et al. · Value in Health

Works count: 12

Citation count: 15

H-index: 1

I10-index: 1